Judge approves $7B Roundup cancer settlement
Archived — this story has rotated out of today’s deck. It is kept here in full.
The gist
A Missouri judge gave final approval to Bayer's $7.25 billion settlement of Roundup cancer claims.
The payout ends most of a decade of litigation weighing on Bayer.
Background
Bayer is the German pharmaceutical and biotech giant that owns Roundup, the weedkiller Monsanto debuted in 1974; Bayer inherited the product's legal troubles when it bought Monsanto for $63 billion in 2018. Plaintiffs claim Roundup caused non-Hodgkin lymphoma, a type of cancer, and Bayer denies the product causes cancer. The settlement follows a June U.S. Supreme Court ruling that Bayer cannot be sued in state courts over the absence of a cancer warning label, which undercut a central argument in the lawsuits.
How it unfolded
- 2015The World Health Organization's International Agency for Research on Cancer classified glyphosate, Roundup's active ingredient, as "probably carcinogenic" to humans.
- 2018Bayer acquired Monsanto for $63 billion, inheriting the Roundup litigation.
- 2020Bayer agreed to a $10.9 billion settlement but failed to secure approval for a separate agreement covering future cases.
- Feb 18, 2026Bayer proposed a plan to pay over $7 billion to settle Roundup cancer lawsuits, facing about 65,000 plaintiffs in U.S. courts.
- Mar 4, 2026A Missouri court granted preliminary approval to the $7.25 billion settlement.
- Jun 2026The U.S. Supreme Court ruled 7-2 in favor of Bayer, saying it cannot be sued in state courts because federal regulations do not mandate a cancer warning label; the ruling overturned a $1.25 million award to a Missouri man.
- Oct 2026A Missouri jury sided with Bayer in the first Roundup verdict since the Supreme Court ruling, a case alleging design defects, negligence and fraud.
- Nov 20, 2026A Missouri state court gave final approval to the $7.25 billion nationwide settlement. Bayer will pay into a fund over 21 years, with individual payments of $10,000 to $165,000 depending on severity of cancer, age, occupation, frequency of use, diagnosis date and exposure length; $600 million covers attorneys' fees.
Key terms
- mass tort
- A civil action in which many plaintiffs sue one or a few defendants over injuries from the same or similar harm.
- class action
- A lawsuit in which one or a few people sue on behalf of a larger group of similarly situated parties.
- non-Hodgkin lymphoma
- A group of blood cancers that includes all lymphomas except Hodgkin lymphoma.
Source: Wikipedia
Who’s saying what
- Official
- Judge Timothy Boyer called the awards "fair, reasonable, and adequate" and said the settlement is among the largest in the history of mass tort personal-injury class action settlements.
- Bulls
- Bayer chief executive Bill Anderson called the court's final approval "a decisive milestone" in the company's strategy to mitigate the risks of pending and future Roundup litigation.
- Support
- Plaintiffs' lawyer Christopher Seeger said the final approval order delivers guaranteed compensation to Roundup cancer victims who have waited more than a decade for justice.
- Caution
- Some attorneys for cancer patients objected that the settlement funds were not enough and the payouts too small; Judge Boyer rejected the objections, saying further delays could leave seriously ill patients waiting years for compensation.
Still unverified
Whether glyphosate causes cancer remains disputed: the WHO's cancer agency classified it as "probably carcinogenic" in 2015, while the U.S. Environmental Protection Agency says it is unlikely to cause cancer when used as directed, and Bayer denies Roundup causes cancer. The ruling could still be appealed.